Biglari S, Moghaddam A, Tabatabaiefar M, Sherkat R, Youssefian L, Saeidian A
Genet Med. 2023; 26(2):101028.
PMID: 37978863
PMC: 10922824.
DOI: 10.1016/j.gim.2023.101028.
Czarny J, Andrzejewska M, Zajac-Spychala O, Latos-Grazynska E, Pastorczak A, Wypyszczak K
Int J Mol Sci. 2023; 24(2).
PMID: 36674612
PMC: 9866559.
DOI: 10.3390/ijms24021099.
Huisman E, Brooimans A, Mayer S, Joosten M, de Bont L, Dekker M
J Clin Immunol. 2022; 42(7):1521-1534.
PMID: 35763218
PMC: 9674766.
DOI: 10.1007/s10875-022-01303-8.
Petley E, Yule A, Alexander S, Ojha S, Whitehouse W
PLoS One. 2022; 17(3):e0264177.
PMID: 35290391
PMC: 9049793.
DOI: 10.1371/journal.pone.0264177.
Rawat A, Tyagi R, Chaudhary H, Pandiarajan V, Jindal A, Suri D
Sci Rep. 2022; 12(1):4036.
PMID: 35260754
PMC: 8904522.
DOI: 10.1038/s41598-022-08019-0.
Atypical Ataxia Presentation in Variant Ataxia Telangiectasia: Iranian Case-Series and Review of the Literature.
Shad T, Yazdani R, Amirifar P, Delavari S, Heidarzadeh Arani M, Mahdaviani S
Front Immunol. 2022; 12:779502.
PMID: 35095854
PMC: 8795590.
DOI: 10.3389/fimmu.2021.779502.
ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer.
Putti S, Giovinazzo A, Merolle M, Falchetti M, Pellegrini M
Cancers (Basel). 2021; 13(21).
PMID: 34771661
PMC: 8583659.
DOI: 10.3390/cancers13215498.
Compound heterozygous variants including a novel copy number variation in a child with atypical ataxia-telangiectasia: a case report.
Lee H, Jang D, Kim J, Lee D, Jang J, Joo J
BMC Med Genomics. 2021; 14(1):204.
PMID: 34404412
PMC: 8371864.
DOI: 10.1186/s12920-021-01053-3.
Six Novel ATM Gene Variants in Sri Lankan Patients with Ataxia Telangiectasia.
Hettiarachchi D, Panchal H, Pathirana B, Rathnayaka P, Padeniya A, Lai P
Case Rep Genet. 2020; 2020:6630300.
PMID: 33376610
PMC: 7744220.
DOI: 10.1155/2020/6630300.
Ataxia telangiectasia: a review.
Rothblum-Oviatt C, Wright J, Lefton-Greif M, McGrath-Morrow S, Crawford T, Lederman H
Orphanet J Rare Dis. 2016; 11(1):159.
PMID: 27884168
PMC: 5123280.
DOI: 10.1186/s13023-016-0543-7.
Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.
Claes K, Depuydt J, Taylor A, Last J, Baert A, Schietecatte P
Neuromolecular Med. 2013; 15(3):447-57.
PMID: 23632773
DOI: 10.1007/s12017-013-8231-4.
Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.
Mitui M, Nahas S, Du L, Yang Z, Lai C, Nakamura K
Hum Mutat. 2008; 30(1):12-21.
PMID: 18634022
PMC: 2776735.
DOI: 10.1002/humu.20805.
Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.
Staples E, McDermott E, Reiman A, Byrd P, Ritchie S, Taylor A
Clin Exp Immunol. 2008; 153(2):214-20.
PMID: 18505428
PMC: 2492895.
DOI: 10.1111/j.1365-2249.2008.03684.x.
Molecular pathology of ataxia telangiectasia.
Taylor A, Byrd P
J Clin Pathol. 2005; 58(10):1009-15.
PMID: 16189143
PMC: 1770730.
DOI: 10.1136/jcp.2005.026062.
The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.
Stray-Pedersen A, Jonsson T, Heiberg A, Lindman C, Widing E, Aaberge I
Clin Exp Immunol. 2004; 137(1):179-86.
PMID: 15196260
PMC: 1809075.
DOI: 10.1111/j.1365-2249.2004.02492.x.
